411EGP
- Active ingredient
- solifenacin+mirabegron
- Strength
- 5/50mg
- Form
- tablet
- Manufacturer
- hikma
- Route
- oral.solid
Uses
Used for treatment of overactive bladder with symptoms such as urgency, increased urinary frequency, and urge urinary incontinence.
Do not use if
Urinary retention, gastric retention, uncontrolled severe hypertension, or hypersensitivity to any ingredient.
Side effects
Dry mouth, constipation, urinary tract infection, headache, and increased blood pressure may occur.
Warnings
Monitor blood pressure and urinary symptoms during treatment.
How it works
Mirabegron stimulates beta-3 adrenergic receptors in the bladder, while solifenacin blocks muscarinic receptors to reduce bladder overactivity.
Storage
Store at room temperature.